These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 8983642

  • 1. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A, Monaci N, Bonassi ME, Corna D, Zoja C, Mohammed EI, Remuzzi G.
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [Abstract] [Full Text] [Related]

  • 4. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 5. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C, Benigni A, Camozzi D, Corna D, Longaretti L, Todeschini M, Remuzzi G.
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [Abstract] [Full Text] [Related]

  • 6. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Sep; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 7. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [Abstract] [Full Text] [Related]

  • 8. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S, Vaquero M, Gómez-Guerrero C, López D, Egido J, Romero R.
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G.
    Exp Nephrol; 1996 Apr; 4(1):19-25. PubMed ID: 8788596
    [Abstract] [Full Text] [Related]

  • 10. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G.
    Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
    [Abstract] [Full Text] [Related]

  • 11. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A, Amann K, Wagner J, Gehlen F, Münter K, Ritz E.
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 Mar; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T, Cybulsky AV, Cupples WA, Ajikobi DO, Papillon J, Aoudjit L.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
    Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G.
    Kidney Int; 1998 Aug; 54(2):353-9. PubMed ID: 9690201
    [Abstract] [Full Text] [Related]

  • 15. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP, Tramontano A.
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [Abstract] [Full Text] [Related]

  • 16. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Nov; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 17. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C, Corna D, Gagliardini E, Conti S, Arnaboldi L, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [Abstract] [Full Text] [Related]

  • 18. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
    Renaud IM, Chainey A, Belair MF, Mandet C, Michel O, Myara I, Chevalier J, Plante GE.
    Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
    [Abstract] [Full Text] [Related]

  • 19. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A.
    Exp Nephrol; 1998 Apr; 6(2):121-31. PubMed ID: 9567218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.